Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01539655 · ClinicalTrials.gov registry record · Phase 1
Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib
A Phase 1 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT01539655 is a Phase 1 study that has completed, run by Sanofi. The registered enrollment target is 34 participants.
The verdict
NCT01539655, a Phase 1 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
Study in healthy volunteers to assess effect of omeprazole and ranitidine on the pharmacokinetics of vandetanib
Interventions
- DRUG omeprazole
- DRUG vandetanib
- DRUG ranitidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01539655
The ClinicalTrials.gov registry entry for NCT01539655 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which omeprazole is the first listed.
NCT01539655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01539655 about?
NCT01539655 is a clinical study titled "Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib". Study in healthy volunteers to assess effect of omeprazole and ranitidine on the pharmacokinetics of vandetanib
What is the current status of trial NCT01539655?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2012-02. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01539655?
The interventions under investigation include: omeprazole (DRUG), vandetanib (DRUG), ranitidine (DRUG).
Who is sponsoring clinical trial NCT01539655?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.